Anne Chew

17.1k total citations · 4 hit papers
34 papers, 9.6k citations indexed

About

Anne Chew is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Anne Chew has authored 34 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 10 papers in Immunology and 8 papers in Genetics. Recurrent topics in Anne Chew's work include CAR-T cell therapy research (24 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Virus-based gene therapy research (7 papers). Anne Chew is often cited by papers focused on CAR-T cell therapy research (24 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Virus-based gene therapy research (7 papers). Anne Chew collaborates with scholars based in United States and Switzerland. Anne Chew's co-authors include Carl H. June, Bruce L. Levine, Stephan A. Grupp, David L. Porter, David T. Teachey, David M. Barrett, Richard Aplenc, Susan R. Rheingold, Simon F. Lacey and J. Joseph Melenhorst and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Anne Chew

32 papers receiving 9.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

2014 3.9k citations Shannon L. Maude, Noelle V. Frey et al. New England Journal of Medicine profile →
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

2013 2.6k citations Stephan A. Grupp, Michael Kalos et al. New England Journal of Medicine profile →
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

2015 1.3k citations David Porter, Wei‐Ting Hwang et al. profile →
Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies

2013 693 citations Gregory L. Beatty, Andrew R. Haas et al. Cancer Immunology Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Chew United States	19	8.4k	3.3k	2.6k	2.5k	2.3k	34	9.6k
Shannon L. Maude United States	33	7.7k 0.9×	2.5k 0.8×	2.2k 0.8×	2.1k 0.8×	1.9k 0.8×	107	9.2k
J. Joseph Melenhorst United States	38	11.1k 1.3×	4.0k 1.2×	3.1k 1.2×	3.5k 1.4×	3.2k 1.4×	122	12.7k
Zhaohui Zheng United States	17	5.6k 0.7×	2.1k 0.6×	1.7k 0.7×	1.8k 0.7×	1.5k 0.7×	32	6.5k
Nirali N. Shah United States	34	6.0k 0.7×	2.0k 0.6×	1.8k 0.7×	1.8k 0.7×	1.6k 0.7×	219	7.4k
Vanessa Gonzalez United States	8	5.0k 0.6×	1.8k 0.5×	1.5k 0.6×	1.5k 0.6×	1.4k 0.6×	20	5.6k
Yolanda D. Mahnke United States	19	4.4k 0.5×	2.6k 0.8×	1.2k 0.5×	1.7k 0.7×	1.1k 0.5×	32	6.4k
Saar Gill United States	39	4.4k 0.5×	3.0k 0.9×	1.3k 0.5×	2.0k 0.8×	1.0k 0.5×	174	6.9k
Michael Hudecek Germany	39	5.4k 0.6×	2.0k 0.6×	1.6k 0.6×	2.4k 0.9×	1.9k 0.8×	112	6.4k
Claudia Rössig Germany	35	4.4k 0.5×	2.4k 0.7×	1.4k 0.5×	1.4k 0.5×	951 0.4×	157	5.8k

Countries citing papers authored by Anne Chew

Since Specialization

Citations

This map shows the geographic impact of Anne Chew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Chew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Chew more than expected).

Fields of papers citing papers by Anne Chew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Chew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Chew. The network helps show where Anne Chew may publish in the future.

Co-authorship network of co-authors of Anne Chew

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Chew. A scholar is included among the top collaborators of Anne Chew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Chew. Anne Chew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jadlowsky, Julie K., Rachel Leskowitz, S.J. McKenna, et al.. (2024). Long-term stability of clinical-grade lentiviral vectors for cell therapy. Molecular Therapy — Methods & Clinical Development. 32(1). 101186–101186. 7 indexed citations

Tanyi, János L., Mark H. O’Hara, Elizabeth O. Hexner, et al.. (2023). 671 Phase 1 trial of human chimeric antigen receptor modified T cells (huCART-meso) administered in combination with oncolytic virus VCN-01 in patients with pancreatic and ovarian cancer. SHILAP Revista de lepidopterología. A760–A761.

Jung, In-Young, Estela Noguera-Ortega, Erik F. Williams, et al.. (2023). Tissue-resident memory CAR T cells with stem-like characteristics display enhanced efficacy against solid and liquid tumors. Cell Reports Medicine. 4(6). 101053–101053. 36 indexed citations

Cornetta, Kenneth, Cameron J. Turtle, Michael C. Jensen, et al.. (2017). Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products. Molecular Therapy. 26(1). 280–288. 64 indexed citations

Marcucci, Katherine T., Julie K. Jadlowsky, Wei‐Ting Hwang, et al.. (2017). Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients. Molecular Therapy. 26(1). 269–279. 91 indexed citations

Schuster, Stephen J., Jakub Svoboda, Sunita D. Nasta, et al.. (2016). Treatment with Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) Results in Durable Remissions in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphomas of Germinal Center and Non-Germinal Center Origin, "Double Hit" Diffuse Large B Cell Lymphomas, and Transformed Follicular to Diffuse Large B Cell Lymphomas. Blood. 128(22). 3026–3026. 15 indexed citations

Porter, David L., Norbert Frey, Jan J. Melenhorst, et al.. (2016). Randomized, phase II dose optimization study of chimeric antigen receptor (CAR) modified T cells directed against CD19 in patients (pts) with relapsed, refractory (R/R) CLL.. Journal of Clinical Oncology. 34(15_suppl). 3009–3009. 28 indexed citations

Chong, Elise A., Jakub Svoboda, Sunita D. Nasta, et al.. (2016). Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) in Patients with Poor Prognosis, Relapsed or Refractory CD19+ Follicular Lymphoma: Prolonged Remissions Relative to Antecedent Therapy. Blood. 128(22). 1100–1100. 18 indexed citations

Schuster, Stephen J., Jakub Svoboda, Sunita D. Nasta, et al.. (2016). Recovery of humoral immunity in patients with durable complete responses following chimeric antigen receptor modified t cells directed against CD19 (CTL019).. Journal of Clinical Oncology. 34(15_suppl). 7564–7564. 7 indexed citations

10.

Porter, David L., Simon F. Lacey, Wei‐Ting Hwang, et al.. (2014). Cytokine Release Syndrome (CRS) after Chimeric Antigen Receptor (CAR) T Cell Therapy for Relapsed/Refractory (R/R) CLL. Blood. 124(21). 1983–1983. 6 indexed citations

11.

Maude, Shannon L., Noelle V. Frey, Pamela A. Shaw, et al.. (2014). Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia. New England Journal of Medicine. 371(16). 1507–1517. 3933 indexed citations breakdown →

12.

Beatty, Gregory L., Andrew R. Haas, Marcela V. Maus, et al.. (2013). Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies. Cancer Immunology Research. 2(2). 112–120. 693 indexed citations breakdown →

13.

Grupp, Stephan A., Michael Kalos, David M. Barrett, et al.. (2013). Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia. New England Journal of Medicine. 368(16). 1509–1518. 2631 indexed citations breakdown →

14.

Porter, David L., Michael Kalos, Norbert Frey, et al.. (2013). Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019 cells) Have Long-Term Persistence and Induce Durable Responses In Relapsed, Refractory CLL. Blood. 122(21). 4162–4162. 22 indexed citations

15.

Zhao, Yangbing, Edmund K. Moon, Carmine Carpenito, et al.. (2010). Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor. Cancer Research. 70(22). 9053–9061. 366 indexed citations

16.

Stadtmauer, Edward A., Dan T. Vogl, Eline T. Luning Prak, et al.. (2010). Transfer of influenza vaccine–primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial. Blood. 117(1). 63–71. 27 indexed citations

17.

Chew, Anne, Giorgio Sirugo, John P. Alsobrook, & Grazia Isaya. (2000). Functional and Genomic Analysis of the Human Mitochondrial Intermediate Peptidase, a Putative Protein Partner of Frataxin. Genomics. 65(2). 104–112. 20 indexed citations

18.

Chew, Anne, et al.. (1997). Cloning, Expression, and Chromosomal Assignment of the Human Mitochondrial Intermediate Peptidase Gene (MIPEP). Genomics. 40(3). 493–496. 26 indexed citations

19.

Chew, Anne, et al.. (1996). Mutations in a Putative Zinc-Binding Domain Inactivate the Mitochondrial Intermediate Peptidase. Biochemical and Biophysical Research Communications. 226(3). 822–829. 12 indexed citations

20.

Monestier, Marc, Anne Chew, Kuppuswamy N. Kasturi, et al.. (1988). Specificities and V genes encoding monoclonal autoantibodies from viable motheaten mice.. The Journal of Experimental Medicine. 167(3). 1137–1153. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact